They aren't just "pandemic stocks." ...

Moderna has filed a lawsuit against Pfizer and its German partner BioNTech for allegedly copying their COVID-19 vaccine. On Friday, Moderna issued a news release accusing Pfizer of infringing several ...

New research shows promising signs that the Pfizer and Moderna vaccines might offer protection for a longer time than previously thought. And that protection could potentially last for years Health ...

WASHINGTON — Pfizer and Moderna say the Food and Drug Administration have opened up COVID-19 booster shots to all adults, letting them choose another dose of either vaccine. The move expands the ...

The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up. The Centers for Disease Control and ...

GSK has secured an FDA expansion for its respiratory syncytial virus (RSV) vaccine, Arexvy, for adults ages 18 to 49 who are at increased risk of lower respiratory tract disease caused by the virus.

The packing and shipping of a third COVID-19 vaccine approved for use in the U.S. is underway. Johnson & Johnson’s single-dose shot will start going into Americans’ arms in a matter of days. Nearly 4 ...